Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2022-02-14Clinical Trial Update: A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303) [Phase 3]
Phase 3 trial comparing montelukast with fluticasone in pediatric chronic asthma was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2022-02-01Clinical Trial Update: Benralizumab in the Treatment of Patients With Severe Asthma With ABPA [Phase 4]
A Phase 4 trial evaluating benralizumab for severe asthma with ABPA has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-12-14Clinical Trial Update: Investigating the Effects of QVM149 on MRI Ventilation Defects [Phase 3]
Phase 3 trial investigating QVM149 for asthma with status listed as withdrawn.
-
EMA withdrawal · 2021-03-19EMA Application withdrawn: Dexamethasone Taw (Dexamethasone (sodium phosphate)) — Taw Pharma (Ireland) Ltd
EMA withdrew the application for Dexamethasone Taw (dexamethasone sodium phosphate) by Taw Pharma (Ireland) Ltd.
-
CLINICAL_TRIALS withdrawal · 2020-09-07Clinical Trial Update: Nebulized Magnesium Sulfate in Pediatric Asthma [Phase 3]
A Phase 3 trial evaluating nebulized magnesium sulfate for pediatric asthma was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2020-01-15EMA Withdrawn: Aerivio Spiromax (salmeterol xinafoate;fluticasone propionate) — Teva B.V.
EMA withdrew Aerivio Spiromax (salmeterol xinafoate; fluticasone propionate) from Teva B.V., a pulmonary disease and asthma medication.
-
CLINICAL_TRIALS withdrawal · 2019-09-13Clinical Trial Update: Inhaled Corticosteroids on Airway Smooth Muscle in Asthma [Phase 4]
Phase 4 trial investigating inhaled corticosteroids on airway smooth muscle in asthma was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-07-17Clinical Trial Update: Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Mild to Moderate Persistent Asthma [Phase 3]
Phase 3 trial investigating Beclomethasone Dipropionate HFA for mild to moderate persistent asthma was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-07-17Clinical Trial Update: Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Persistent Asthma [Phase 3]
Phase 3 trial of beclomethasone dipropionate HFA in adults and adolescents with persistent asthma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-07-05Clinical Trial Update: Randomized, Placebo-controlled Study Comparing Efficacy of Fluticasone/Salmeterol Combination to Advair in Asthmatics [Phase 3]
A Phase 3 randomized, placebo-controlled trial comparing a fluticasone/salmeterol combination to Advair in asthmatics was withdrawn.
-
EMA withdrawal · 2019-07-02EMA Withdrawn: Airexar Spiromax (salmeterol;fluticasone propionate) — Teva B.V.
EMA has withdrawn Airexar Spiromax (salmeterol; fluticasone propionate) from the market.
-
CLINICAL_TRIALS withdrawal · 2019-03-25Clinical Trial Update: Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled Asthma [Phase 3]
Phase 3 trial comparing FF/UMEC/VI vs FP/SAL plus tiotropium in inadequately controlled asthma was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-02-04Clinical Trial Update: Description of the Ability to Learn How to Handle Inhaler Devices in Asthma [NA]
Clinical trial update notes withdrawal of a study investigating the ability to learn how to handle inhaler devices for asthma.
-
CLINICAL_TRIALS withdrawal · 2019-01-31Clinical Trial Update: A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects [Phase 2]
Pfizer's Phase 2 study of PF-00610355 in moderately asthmatic subjects has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-06-18Clinical Trial Update: Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children [Phase 3]
A Phase 3 trial evaluating the combination of Beclomethasone Dipropionate and Formoterol Fumarate versus single components in asthmatic chil…
-
CLINICAL_TRIALS withdrawal · 2018-05-08Clinical Trial Update: Repeated High-dose Inhaled Corticosteroids for Asthma [Phase 2]
Phase 2 trial evaluating repeated high-dose inhaled corticosteroids for asthma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-04-25Clinical Trial Update: A Single-Arm Study to Evaluate Administration of Lebrikizumab by Participants or Caregivers in the Home Setting [Phase 3]
The document notes the withdrawal of a Phase 3 single-arm trial evaluating home administration of Lebrikizumab for asthma.
-
CLINICAL_TRIALS withdrawal · 2018-03-13Clinical Trial Update: Dose Finding Study of Albuterol Sulfate in Patients With Intermittent or Persistent Mild Asthma [Phase 2]
A Phase 2 dose-finding trial of albuterol sulfate for intermittent or persistent mild asthma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-01-29Clinical Trial Update: The Efficacy of Fluticasone Furoate/Vilanterol Versus (vs) Fluticasone Furoate on Asthma [Phase 4]
Phase 4 trial comparing fluticasone furoate/vilanterol to fluticasone furoate in asthma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-08-29Clinical Trial Update: Leiden University Medical Center Mini Donor Bank
Leiden University Medical Center's Mini Donor Bank trial (NCT02810613) has been withdrawn; the listed conditions include malaria, Schistosom…
-
CLINICAL_TRIALS withdrawal · 2017-08-24Clinical Trial Update: Noninvasive Positive Airway Pressure in the Pediatric Emergency Department for the Treatment of Acute Asthma Exacerbations [NA]
A pediatric trial evaluating noninvasive positive airway pressure for acute asthma exacerbations has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: Pioglitazone Hydrochloride (Actos(Registered Trademark)) to Treat Asthma [Phase 2]
A Phase 2 trial of pioglitazone hydrochloride (Actos) for asthma sponsored by NHLBI has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-06-07Clinical Trial Update: GSK2190915 Pediatric Study [Phase 2]
A pediatric Phase 2 study of GSK2190915 for asthma has been withdrawn from the clinical trial program.
-
CLINICAL_TRIALS withdrawal · 2017-05-05Clinical Trial Update: Evaluation of a Nasal Allergen Challenge Procedure Using Dust Mite Extract [Phase 1]
Phase 1 evaluation of a nasal allergen challenge using dust mite extract was withdrawn. The study targeted dust mite allergy and asthma.
-
CLINICAL_TRIALS withdrawal · 2017-04-20Clinical Trial Update: A Study to Evaluate the Effects of Indacaterol Maleate (QAB149) as a New Formulation in the EPIC Test Fixture [Phase 2]
A Phase 2 trial evaluating a new formulation of indacaterol maleate (QAB149) for asthma has been withdrawn.